ࡱ> DC g2\pGriffiths Pamela Ba==@k-8X@"1"Calibri1"Calibri1"Calibri1"Calibri1"Calibri1"Calibri1"Calibri1"Calibri1h8"Cambria1,8"Calibri18"Calibri18"Calibri1"Calibri1"Calibri1<"Calibri1>"Calibri1?"Calibri14"Calibri14"Calibri1 "Calibri1 "Calibri1"Calibri1 "Calibri""#,##0;\-""#,##0""#,##0;[Red]\-""#,##0""#,##0.00;\-""#,##0.00#""#,##0.00;[Red]\-""#,##0.005*0_-""* #,##0_-;\-""* #,##0_-;_-""* "-"_-;_-@_-,)'_-* #,##0_-;\-* #,##0_-;_-* "-"_-;_-@_-=,8_-""* #,##0.00_-;\-""* #,##0.00_-;_-""* "-"??_-;_-@_-4+/_-* #,##0.00_-;\-* #,##0.00_-;_-* "-"??_-;_-@_-                                                                       ff + ) , *     P  P        `            a>  (  8!!     0@ @  8"@ @  8"@ @  8 "@ @   8  @   8 @ 8@ @  8@ @  8 @ @  8@ @  8@ @  0@ @  0!@ @  8@ @  0!@ @  8!@ @  0!@ @  0!!@ @  ||T5}-} _-;_-* "}-} _-;_-* "}-} _-;_-* "}-} _-;_-* "}-} _-;_-* "}-} _-;_-* "}-} _-;_-* "}-} _-;_-* "}-} _-;_-* "}-}  _-;_-* "}-}  _-;_-* "}-}  _-;_-* "}-}  _-;_-* "}-}  _-;_-* "}-} _-;_-* "}-} _-;_-* "}-}> _-;_-* "}P}? _-;_-* "?_-;_-@_  }-}@ _-;_-* "}-}A _-;_-* "}-}B _-;_-* "}-}C _-;_-* "}-}D _-;_-* "}-}E _-;_-* "}<}F _-;_-* " ?_-;_-@_}P}G _-;_-* "?_-;_-@_  }(}H _-;_-* "}(}I _-;_-* "}(}J _-;_-* "}(}K _-;_-* "}(}L _-;_-* "}-}M _-;_-* "}-}N _-;_-* "}(}O _-;_-* "}-}P _-;_-* "}(}Q _-;_-* "}-}R _-;_-* "}-}S _-;_-* "}-}+ _-;_-* "}-}, _-;_-* "}-}- _-;_-* "}-}. _-;_-* "}-}: _-;_-* "}-}; _-;_-* "}A}1 _-;_-* "-@_ }A}2 _-;_-* "?-@_ }A}3 _-;_-* "23-@_ }-}4 _-;_-* "}A}0 a_-;_-* "-@_ }A}( _-;_-* "-@_ }A}7 e_-;_-* "-@_ }}5 ??v_-;_-* "̙-@_    }}9 ???_-;_-* "-@_ ??? ??? ??? ???}}) }_-;_-* "-@_    }A}6 }_-;_-* "-@_ }}* _-;_-* "-@_ ??? ??? ??? ???}-}= _-;_-* "}}8 _-;_-* "-@_    }-}/ _-;_-* "}U}< _-;_-* "-@_  }A}" _-;_-* "-@_ }A} _-;_-* "ef-@_ }A} _-;_-* "L-@_ }A} _-;_-* "23-@_ }A}# _-;_-* "-@_ }A} _-;_-* "ef-@_ }A} _-;_-* "L-@_ }A} _-;_-* "23-@_ }A}$ _-;_-* "-@_ }A} _-;_-* "ef-@_ }A} _-;_-* "L-@_ }A} _-;_-* "23-@_ }A}% _-;_-* "-@_ }A} _-;_-* "ef-@_ }A} _-;_-* "L-@_ }A} _-;_-* "23-@_ }A}& _-;_-* "-@_ }A} _-;_-* "ef-@_ }A} _-;_-* "L-@_ }A}  _-;_-* "23-@_ }A}' _-;_-* " -@_ }A} _-;_-* "ef -@_ }A} _-;_-* "L -@_ }A}! _-;_-* "23 -@_  20% - Accent1M 20% - Accent1 ef % 20% - Accent2M" 20% - Accent2 ef % 20% - Accent3M& 20% - Accent3 ef % 20% - Accent4M* 20% - Accent4 ef % 20% - Accent5M. 20% - Accent5 ef % 20% - Accent6M2 20% - Accent6  ef % 40% - Accent1M 40% - Accent1 L % 40% - Accent2M# 40% - Accent2 L渷 % 40% - Accent3M' 40% - Accent3 L % 40% - Accent4M+ 40% - Accent4 L % 40% - Accent5M/ 40% - Accent5 L % 40% - Accent6M3 40% - Accent6  Lմ % 60% - Accent1M 60% - Accent1 23 % 60% - Accent2M$ 60% - Accent2 23ږ % 60% - Accent3M( 60% - Accent3 23כ % 60% - Accent4M, 60% - Accent4 23 % 60% - Accent5M0 60% - Accent5 23 %! 60% - Accent6M4 60% - Accent6  23 % "Accent1AAccent1 O % #Accent2A!Accent2 PM % $Accent3A%Accent3 Y % %Accent4A)Accent4 d % &Accent5A-Accent5 K % 'Accent6A1Accent6  F %(Bad9Bad  %) Calculation Calculation  }% * Check Cell Check Cell  %????????? ???+ Comma,( Comma [0]-&Currency.. Currency [0]/Explanatory TextG5Explanatory Text % 0Good;Good  a%1 Heading 1G Heading 1 I}%O2 Heading 2G Heading 2 I}%?3 Heading 3G Heading 3 I}%234 Heading 49 Heading 4 I}% 5InputuInput ̙ ??v% 6 Linked CellK Linked Cell }% 7NeutralANeutral  e%3Normal % 8Noteb Note   9OutputwOutput  ???%????????? ???:$Percent ;Title1Title I}% <TotalMTotal %OO= Warning Text? Warning Text %XTableStyleMedium2PivotStyleLight16`:Sheet1yaSheet2bSheet3,  ;8s86 Drug Name Total Usage Acitretin Alitretinoin PimecrolimusDupixent (Dupilumab)XPhototherapy including with ultraviolet (UVB) radiation or psoralen ultraviolet A (PUVA)Amcinonide 0.05% (Cyclocort)-Betamethasone diproprionate 0.05% (Diprosone)Betamethasone valerateClobetasol proionateDesoximetasone 0.25% (Topicort)Diflucortolone valerateFluocinonide 0.05% (Lidex))Fluticasone proprionate 0.005% (Cutivate)Halcinonide 0.05% (Halog))Mometasone furoate 0.1% (Elocon ointment)7Triamcinalone acetonide 0.5% (Kenalog, Aristocrt cream),Betamethasone dipropionate 0.25% (Diprolene)(Clobetasol dipropionate 0.05% (Temovate)%Diflorasone diacetate 0.05% (Psorcon)(Halbetasol proprionate 0.05% (Ultravate) Azathioprine Ciclosporin Methotrexate Etanercept Infliximab Adalimumab Ustekinumab 5743 capsules 324 capsules3240gTIMS AND PARKER (SEP-NOV 2018)10,380g12,380g2730g 5292 capsules 2305 capsulesHOMECARE (SEP-NOV 2018)WWL (SEP-NOV 2018)10,311 tablets, 199 SC pens0 tablets, 3262 SC pens 2760 devices51 bags 1898 devices 71 devices 1066 capsules 66 capsules7 x 30g 6716 tablets54 cream(30g), 8 ointment, 1421 capsules, 5 injectionsE2789 capsules, 15 eye drops, 138 solution, 3 concentrate for infusion41759 PF pen, oral sol 70, 5610 tablets, IM injection 2 PF syringe:4 w5x678}8 .9ccB g2 X`  dMbP?_*+%"&ffffff?'ffffff?(?)?M\\WWLXerPS1\Xerox_Follow_You0C 4dXXA4 (210 x 297 mm)DINU"D~SMTJXerox PullPrn PCL6 V4.0.548.8.0RESDLLUniresDLLXrxTrueTypeFontDlOptionTTF_DOWNLOAD_AS_TRUETYPEXrxEdgeToEdgeEDGE_TO_EDGE_OFFColorMode24bppXrxHalftoneXRX_NORMAL_HTXEROX_JOB_SETUP_BEGINCBXEROX_JOB_SETUP_ENDCBXEROX_DOC_BEGINCBXEROX_DOC_SETUP_ENDCBXEROX_PAGE_SETUP_BEGINCBXEROX_PAGE_SETUP_ENDCBXEROX_PAGE_FINISH_BEGINCBXEROX_PAGE_FINISH_ENDCBXEROX_DOC_FINISH_BEGINCBXEROX_DOC_FINISH_ENDCBXEROX_JOB_FINISH_BEGINCBXEROX_JOB_FINISH_ENDCBOrientationPORTRAITCollateONDuplexVERTICALResolutionRes600x600PaperSizeA4D1NRX <   MSCF,90R)//Uncompressed-Data//uR3)CKZklU>;---: mCv ӇliKDi-P(BĀC>W V A &&D21=nY~{vo=;-+_Q˴[ RV*ՂiDZj4'>kdn @ԎLts0^J4RJZ|Y;g(^HO&n3w`~^S8B.z4to^0ݛKK#kzrY ayB;"ug@ UqgGk#3 1ka}$ OgNR&=0`8Y\\*,:O`Qhvt9E/3-2a19cF'rB I*W_<9=MUDnS5uQ FL \vu6CpJ¡ٵxQnej ث3,qb9Wnm9TBsT[! 6v|yyTP I{A:Ū\0'Y^X ߴAg S9VsF7Cp%` -v'E=%?i;/83_"V~m$/xdtM|ڄHa]m0֊W-qU~Td]N#+KuDw:7{wAW}Kqr ӬS̗sW*Vs3n8)BMȜ ^/¼*F=t >īDr8et:CcbgZN˨doX8G4m )n~+{Y boWxUW;qpve^*w /q$X1>Fj0;$u!j+V4P/kSTڂy1D Fd^\РRG Tdxqt\oesZ w{pk8N@^?iL6.6 +,=n]Qd vw\ٝtHR4[GDv҂äNyi{م3iy!-]sH gWCZ5} A} Ag J@ @@ @@ @ @@ v@ @@ v@  @@  @@  @@  @@  @@ @@ @@ @@ v@ v@ @@ @@ @@ @@ @ p@ @@ @@ @@ @@ C D& E' ? H I J F L~ M N. F O~ B P/ F O~ B P2 FOBP FOBP FOBP FOBP? F O! BPO@ F O" BPA@ F  OBP F  OBP F  OBP FOBP FOBP F O#~ B P0 FOBP FOBP FOBP FOBP FOBP F O$~ B P1 F O%~ B P3 F O( K) P4 F~ O B*~ P F~ O B+~ P`w@ F~ O B, P5 G~ Q R-~ S(@>0*8888****22*****8*****888888>@UggD g2 b  dMbP?_*+%"&ffffff?'ffffff?(?)?""333333?333333?&<3U>@ggD g2 d  dMbP?_*+%"&ffffff?'ffffff?(?)?""333333?333333?&<3U>@ggD Oh+'0HPh Gary MastermanGriffiths PamelaMicrosoft Excel@7@3@N\՜.+,0HP X`hp x  Sheet1Sheet2Sheet3Sheet1!Print_Area  Worksheets Named Ranges  !"#$%&'()*+,-./012456789:<=>?@ABRoot Entry FWorkbookdSummaryInformation(3DocumentSummaryInformation8;